TAKEDA-SYR-322/CPH-004



An Open-Label Study to Assess the Effect of Voglibose on the Pharmacokinetics of SYR-322 in Healthy Male Subjects
alogliptin
SYR-322/CPH-004
Not available
Diabetes Mellitus, Type 2
Phase 2
 
Select supporting documents are N/A in English and as such are N/A for sharing at this time.
October 2014